R.PR
REGISTERED-PRINCIPAL REGISTER
10/05/2021
Back to search
Official data from USPTO
CYTEIR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
10/05/2021
Trademark type
Word
Nice classes
5, 42
Filing date
07/11/2019
Registration date
10/05/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/05/2021
Last transaction
10/05/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/01/2020
First use in commerce
11/01/2020
Drawing code
4
Owner type
03
Owner location
Lexington, MA, US
Examiner
MARTIN, EUGENIA K
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cyteir Therapeutics, Inc.
Representatives
Karen Won Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for treatment of cancer and autoimmune diseases; pharmaceutical preparations for use in oncologyhematologyimmunology; synthetic lethal therapies for inducing destruction of diseased cells with DNA damage for medical treatment purposes
Class 42
Research and development of medical tests for analyzing synthetic lethality and DNA damage; research and development of synthetic lethal therapies and biomarkers of synthetic lethality; medical laboratory services; medical testing for scientific research purposes in the field of oncologysynthetic lethalityDNA repair; providing medical and scientific research information in the fields of synthetic lethalityDNA repairsynthetic lethal therapiesoncologyhematologyimmunology; drug discovery services
Publications
History of USPTO decisions and trademark events.
35 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/31/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/28/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/15/2021
DPCC
DIVISIONAL PROCESSING COMPLETE
06/15/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/14/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/15/2021
IUAF
USE AMENDMENT FILED
03/01/2021
DRRR
DIVISIONAL REQUEST RECEIVED
03/01/2021
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
03/01/2021
EISU
TEAS STATEMENT OF USE RECEIVED
03/01/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/22/2020
EX1G
SOU EXTENSION 1 GRANTED
09/18/2020
EXT1
SOU EXTENSION 1 FILED
09/18/2020
EEXT
SOU TEAS EXTENSION RECEIVED
09/18/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/21/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/25/2020
PUBO
PUBLISHED FOR OPPOSITION
02/25/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/17/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/02/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/02/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/22/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/22/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/27/2019
GNRT
NON-FINAL ACTION E-MAILED
09/27/2019
CNRT
NON-FINAL ACTION WRITTEN
09/27/2019
DOCK
ASSIGNED TO EXAMINER
09/26/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/25/2019
ALIE
ASSIGNED TO LIE
09/23/2019
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/16/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/18/2019
NWAP
NEW APPLICATION ENTERED
07/15/2019
Continuous trademark protection
Get notified about every new filing that threatens CYTEIR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.